![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/337 | |
A61K 31/4188 | |||
A61K 31/506 | |||
A61K 45/06 | |||
A61P 35/00 | |||
A61P 43/00 |
(11) | Number of the document | 2670405 |
(13) | Kind of document | T |
(96) | European patent application number | 12706925.0 |
Date of filing the European patent application | 2012-02-03 | |
(97) | Date of publication of the European application | 2013-12-11 |
(45) | Date of publication and mention of the grant of the patent | 2015-09-02 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2012/050513 |
Date | 2012-02-03 |
(87) | Number | WO 2012/104822 |
Date | 2012-08-09 |
(30) | Number | Date | Country code |
PCT/IB2011/0504 | 2011-02-04 | WO |
(72) |
REGENASS, Urs, CH
|
(73) |
Actelion Pharmaceuticals Ltd.,
Gewerbestrasse 16, 4123 Allschwil,
CH
|
(54) | COMBINATIONS COMPRISING MACITENTAN FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME |
COMBINATIONS COMPRISING MACITENTAN FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME |